HUTCHMED DRC logo
HCMHUTCHMED DRC
Trade HCM now
HUTCHMED DRC primary media

About HUTCHMED DRC

HUTCHMED (HKEX:0013), (NASDAQ:HCM) is a global biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company is known for its robust pipeline of innovative drug candidates, several of which are in advanced stages of clinical trials with the aim of addressing unmet medical needs across various regions. HUTCHMED is committed to advancing healthcare by developing highly effective treatments, with a focus on bringing novel solutions to patients worldwide. The company actively collaborates with academic, industrial, and healthcare partners to expand its reach and impact in the healthcare sector.

What is HCM known for?

Snapshot

Public US
Ownership
2000
Year founded
680
Employees
Hong Kong
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations

Produtos e/ou serviços de HUTCHMED DRC

  • Oncology treatments focused on inhibiting cancer cell growth
  • Targeted therapies for solid tumors and hematologic malignancies
  • Research and development in tyrosine kinase inhibitors
  • Global partnerships for drug discovery and development
  • Manufacturing services for pharmaceutical products
  • Clinical trial management and execution services

equipe executiva do HUTCHMED DRC

  • Mr. Chig Fung Cheng BEc, CAActing CEO, CFO & Executive Director
  • Dr. Wei-Guo Su B.Sc., Ph.D.CEO, Chief Scientific Officer & Executive Director (Leave of Absence)
  • Ms. Edith Shih BSE, C.S., CGP, EdM, FCIS, FCS, FCS(PE), M.A., P.ECompany Secretary & Non-Executive Director
  • Ms. Yiling CuiExecutive VP & Head of Operations
  • David NgHead of Investor Relations & Capital Strategies
  • Mr. Charles George Rupert NixonGroup General Counsel
  • Mr. Kin Hung Lee M.B.A.Senior Vice President of Corporate Management & Communications
  • Ms. Selina ZhangSenior Vice President of Global Human Resources
  • Dr. Qingmei Wang Ph.D.Executive Vice President of Business Development & Strategic Alliances
  • Dr. Thomas FuSenior Vice President of Global Quality

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.